TELA Bio (TELA) Earnings Analysis
TELA Bio (TELA) next reports earnings on 2026-08-10, consensus EPS -0.17 USD. Last quarter (2026-03-25) it beat with EPS -0.16 USD vs -0.18 USD est (+11.1%). It has beaten estimates in 2/7 recent quarters (29%). Trailing P/E -0.93.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does TELA next report earnings?
| Next earnings date | 2026-08-10 |
|---|---|
| Consensus EPS estimate | -0.17 USD |
| Revenue estimate | 0.02B |
TELA earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-25 | -0.16 USD | -0.18 USD | +11.1% | Beat |
| 2025-11-13 | -0.19 USD | -0.17 USD | -11.8% | Miss |
| 2025-08-11 | -0.22 USD | -0.18 USD | -22.2% | Miss |
| 2025-05-08 | -0.25 USD | -0.21 USD | -19% | Miss |
| 2025-03-20 | -0.23 USD | -0.24 USD | +4.2% | Beat |
| 2024-11-07 | -0.42 USD | -0.37 USD | -13.5% | Miss |
| 2024-08-12 | -0.51 USD | -0.45 USD | -13.3% | Miss |
Beat rate: 2/7 (29%) over reported quarters with consensus data.
TELA valuation and analyst view
| Trailing P/E | -0.93 |
|---|---|
| Trailing EPS | -0.69582 USD |
| Price / book | -8.07 |
| Dividend yield | 0.00% |
| Market cap | 0.03B |
| Analyst consensus | Buy (7 buy / 1 hold / 0 sell) |
| Avg price target | 2.42 USD |
Related research pages
Frequently asked questions
When is TELA Bio (TELA)'s next earnings date?
TELA Bio is next scheduled to report on 2026-08-10, with a consensus EPS estimate of -0.17 USD and revenue estimate of 0.02B.
Did TELA beat earnings last quarter?
In its 2026-03-25 report, TELA posted EPS of -0.16 USD versus a -0.18 USD estimate — a beat of 11.1%.
What is TELA's earnings track record?
Over the last 7 reported quarters with consensus data, TELA beat estimates 2 times (29%).
What is TELA's current P/E ratio and EPS?
TELA trades at a trailing P/E of -0.93 on trailing EPS of -0.695815976794118 USD.
What do analysts rate TELA?
Analyst consensus is "Buy" across 8 ratings (0 strong buy, 7 buy, 1 hold, 0 sell, 0 strong sell). Average 12-month price target: 2.42 USD.